NTHL1

Protein-coding gene in the species Homo sapiens From Wikipedia, the free encyclopedia

Endonuclease III-like protein 1 is an enzyme that in humans is encoded by the NTHL1 gene.[5][6][7]

AliasesNTHL1, NTH1, OCTS3, hNTH1, FAP3, nth-like DNA glycosylase 1, nth like DNA glycosylase 1
End2,047,866 bp[1]
Quick facts Identifiers, Aliases ...
NTHL1
Identifiers
AliasesNTHL1, NTH1, OCTS3, hNTH1, FAP3, nth-like DNA glycosylase 1, nth like DNA glycosylase 1
External IDsOMIM: 602656; MGI: 1313275; HomoloGene: 1897; GeneCards: NTHL1; OMA:NTHL1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_002528
NM_001318193
NM_001318194

NM_008743
NM_001357615

RefSeq (protein)

NP_001305122
NP_001305123
NP_002519

NP_032769
NP_001344544

Location (UCSC)Chr 16: 2.04 – 2.05 MbChr 17: 24.85 – 24.86 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

As reviewed by Li et al.,[8] NTHL1 is a bifunctional DNA glycosylase that has an associated beta-elimination activity. NTHL1 is usually involved in removing oxidative pyrimidine lesions through base excision repair. NTHL1 catalyses the first step in base excision repair. It cleaves the N-glycosylic bond between the damaged base and its associated sugar residue and then cleaves the phosphodiester bond 3' to the AP site,[9] leaving a 3'-unsaturated aldehyde after beta-elimination and a 5'-phosphate at the termini of the repair gap.[8]

Low expression of NTHL1 is associated with initiation and development of astrocytoma.[10] Low expression of NTHL1 is also found in follicular thyroid tumors.[11]

A germ line homozygous mutation in NTHL1 causes a cancer susceptibility syndrome similar to Lynch syndrome.[12][13]

See also

References

Further reading

Related Articles

Wikiwand AI